Condition

Renal Cell Cancer clinical trials and research

• 15Clinical trials
• 2NIH research projects
• 6Countries

Newest Renal Cell Cancer clinical trials

All recruiting trials (15)

• Contrast-enhanced ultrasound and super-resolution imaging to predict kidney function after nephrectomy

  This project will test whether special ultrasound scans—contrast-enhanced ultrasound and super-resolution imaging—can help predict kidney function and the risk and recovery of acute kidney injury in adults having partial or radical nephrectomy for kidney cancer.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT07294859

• AI-driven real-time 3D kidney model to assist partial nephrectomy

  This trial will test whether an AI-powered real-time 3D kidney model can help surgeons perform laparoscopic or robotic partial nephrectomy for adults with small, localized kidney tumors.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu and 1 other locations · NCT07020169

• Nivolumab plus cabozantinib for older adults with kidney cancer

  This trial tests the combination of nivolumab and cabozantinib in people aged 70 and older with metastatic clear-cell kidney cancer to see how it is used and tolerated in routine care.

  Recruiting Phase 4 Gustave Roussy, Cancer Campus, Grand Paris · Angers and 6 other locations · NCT06934057

• Treating the main kidney tumor in metastatic kidney cancer during immunotherapy

  This trial will see if adding surgery or radiotherapy to the main kidney tumor helps people with metastatic clear‑cell kidney cancer who are already benefiting from anti‑PD1–based therapy live longer.

  Recruiting Phase 4 Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT06903312

• Using AI to predict kidney function after partial kidney removal

  This study is testing if a new AI tool can accurately predict how well your kidneys will work after you have part of one removed due to cancer.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu and 1 other locations · NCT06751498

• Improving management of renal tumors using artificial intelligence

  This study is testing if using artificial intelligence can help doctors better understand and treat kidney tumors by analyzing CT scans and improving surgical decisions.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT06714916

• Using vorolanib for treating advanced kidney cancer

  This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.

  Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT06676527

• Oral Alintegimod with Ipilimumab followed by Nivolumab for advanced cancer

  This study is testing if a new oral medication called Alintegimod, combined with two other cancer treatments, can help people with advanced solid tumors feel better and live longer.

  Recruiting at 4 sites Phase 1/2 7 Hills Pharma, LLC · Aurora, Colorado and 4 other locations · NCT06362369

• Evaluating IBI363 for advanced solid tumors

  This study is testing a new treatment called IBI363 to see if it can help adults with advanced solid tumors like melanoma and lung cancer who have run out of other options.

  Recruiting at 9 sites Phase 2 Innovent Biologics (Suzhou) Co. Ltd. · San Francisco, California and 8 other locations · NCT06281678

• Modi-1 vaccine for advanced cancers

  This study is testing a new vaccine for people with advanced cancers like triple negative breast cancer and ovarian cancer to see if it can boost their immune response and work better with other treatments.

  Recruiting at 13 sites Phase 1/2 Scancell Ltd · Brighton, Default and 15 other locations · NCT05329532

• Evaluating TT-10 and TT-4 for advanced solid tumors

  This study is testing two new drugs, TT-10 and TT-4, to see if they are safe and effective for people with advanced solid tumors who haven't had success with other treatments.

  Recruiting at 2 sites Phase 1/2 Portage Biotech · Los Angeles, California and 1 other locations · NCT04969315

• Creating a registry to analyze the microbiome in patients with urologic cancers

  This study is trying to create a database to see how the bacteria in our bodies might affect the diagnosis and treatment of urologic cancers like prostate and bladder cancer in Korean patients.

  Recruiting Yonsei University · Seoul · NCT04625556

• Creating a registry for personalized medicine in urological cancer patients using circulating tumor DNA

  This study is trying to see if testing blood and urine for tumor DNA can help doctors better diagnose and monitor urological cancers like prostate and bladder cancer in patients who have had surgery.

  Recruiting Yonsei University · Seoul · NCT04197414

• Novel treatments for renal cell cancer

  This study is testing if three different treatments for kidney cancer can help patients before they have surgery to remove the tumor.

  Recruiting at 6 sites Phase 2 Cambridge University Hospitals NHS Foundation Trust · Cambridge, England and 6 other locations · NCT03741426

• Using modified blood cells to treat cancers that express CD70

  This study is testing if modified blood cells can help shrink tumors in patients with certain types of cancer that have CD70.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT02830724

NIH-funded research (2)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Immunotherapy for Kidney Cancer: Advancing Treatments at a Leading Cancer Center

  A cancer center is testing new immunotherapy approaches for kidney cancer to improve patients’ responses and survival.

  NIH research University of Pennsylvania · Philadelphia, United States · NIH-11397822

• Post-diagnosis Changes in Body Weight and Body Composition in Kidney Cancer

  A research study follows people with clear cell kidney cancer to see how their weight and body fat/muscle change after diagnosis and how that relates to their survival.

  NIH research University of California Berkeley · Berkeley, United States · NIH-11373745

Related topics

Quick answers

How many Renal Cell Cancer clinical trials are recruiting right now?

15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (5 trials), United States (4 trials), South Korea (2 trials), United Kingdom (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 4, Phase 4: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →